Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FP7N1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,385
Award facts
- Contract value 100% obligated
- $28,384.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,384.70 to AmerisourceBergen Drug Corp for the supply of Kesimpta (ofatumumab) 20 mg/0.4 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Kesimpta is a B-cell-targeted monoclonal antibody primarily indicated for the treatment of relapsing multiple sclerosis, representing the type of specialized pharmaceutical commodity critical to military and veteran healthcare systems.
This delivery order derives from AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle extending through December 2026. The IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor and established federal healthcare vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which positions it among DLA's key suppliers in the planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FP7N1?
SPE2DB25FP7N1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FP7N1 worth?
The government has obligated $28,385 on SPE2DB25FP7N1.
Is contract SPE2DB25FP7N1 an order under another contract?
Yes. SPE2DB25FP7N1 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP7N1 competed?
The extent of competition for SPE2DB25FP7N1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award